J Korean Endocr Soc.  2009 Sep;24(3):162-164. 10.3803/jkes.2009.24.3.162.

Glucose Counterregulatory Hormone Response During Hypoglycemia due to Endogenous Hyperinsulinemia

• Kim JG

• KMID: 2178177
• DOI: http://doi.org/10.3803/jkes.2009.24.3.162

Abstract

No abstract available.

MeSH Terms

Glucose
Hypoglycemia
Glucose

Reference

1. Hirata Y, Nishimura H, Tominaga M, Ishizu H, Arimichi M. Spontaneous hypoglycemia with insulin-autoimmunity. Nippon Naika Gakkai Zasshi. 1972. 61:1296–1304.

2. Uchigata Y, Hirata Y, Omori Y, Iwamoto Y, Tokunaga K. Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles. Human Immunol. 2000. 61:154–157.

3. Hirata Y, Tominaga M, Ito JI, Noguchi A. Spontaneous hypoglycemia with insulin autoimmunity in Graves' disease. Ann Intern Med. 1974. 81:214–218.

4. Benson EA, Ho P, Wang C, Wu PC, Fredlund PN, Yueng RT. Insulin autoimmunity as a cause of hypoglycemia. Arch Intern Med. 1984. 144:2351–2354.

5. Ichihara K, Shima K, Saito Y, Nonaka K, Tarui S. Mechanism of hypoglycemia observed in a patient with insulin autoimmune syndrome. Diabetes. 1977. 26:500–506.

6. Hirata Y. Methimazole and insulin autoimmune syndrome with hypoglycemia. Lancet. 1983. 29:1037–1038.

7. Blackshear PJ, Rotner HE, Kriauciunas KA, Kahn CR. Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus. Ann Intern Med. 1983. 99:182–184.

8. Uchigata Y, Eguchi Y, Takayama-Hasumi S, Omori Y. Insulin autoimmune syndrome (Hirata Disease): clinical features and epidemiology in Japan. Diabetes Res Clin Pract. 1994. 22:89–94.

9. Lidar M, Rachmani R, Half E, Ravid M. Insulin autoimmune syndrome after therapy with imipenem. Diabetes Care. 1999. 22:524–525.

10. Cavaco B, Uchigata Y, Porto T, Amparo-Santos M, Sobrinho L, Leite V. Hypoglycaemia due to insulin autoimune syndrome: report of two cases with characterisation of HLA alleles and insulin autoiantibodies. Eur J Endocrinol. 2001. 145:311–316.

11. Uchigata Y. The novel agent, alpha lipoic acid, can cause the development of insulin autoimmune syndrome. Intern Med. 2007. 46:1321–1322.

12. Park SH, Lee SW, Jeong GH, Choi CH, Lee SH, Han JH, Kim JG, Ha SW, Kim BW. Two cases of autoimmune insulin syndrome with hypoglycemia. J Korean Endocr Soc. 2001. 16:508–513.

13. Chung JO, Cho DH, Chung DJ, Chung MY. Glucose counterregulatory hormone response during hypoglycemia due to endogenous hyperinsulinemia. J Korean Endocr Soc. 2009. 24:174–180.

14. Cryer PE. Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol. 1993. 264:E149–E155.

15. Boyle PJ, Shah SD, Cryer PE. Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting. Am J Physiol. 1989. 256:E651–E661.

16. Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P, Gerich JE. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes. 1983. 32:134–141.

17. Davis MR, Shamoon H. Deficient counterregulatory hormone responses during hypoglycemia in a patient with insulinoma. J Clin Endocrinol Metab. 1991. 72:788–792.